Le Lézard
Classified in: Health, Business
Subjects: NPT, VEN

Global Fund Announces US$14 Billion Target to Step Up the Fight Against AIDS, TB and Malaria Ahead of Lyon Conference in October 2019


PARIS, January 11, 2019 /PRNewswire/ --

The Global Fund today announced its fundraising target for the next three-year cycle, outlining how a minimum of US$14 billion will help save 16 million lives, cut the mortality rate from HIV, TB and malaria in half, and build stronger health systems by 2023. The summary of the Sixth Replenishment Investment Case describes what can be achieved by a fully funded Global Fund, the new threats facing global health progress today, and the risks if we don't step up the fight now.

French President Emmanuel Macron expressed his strong support for the Global Fund's replenishment target today. Joined in Paris by Global Fund Executive Director Peter Sands, World Health Organization Director-General Dr. Tedros Adhanom Ghebreyesus, and French Minister of Solidarity and Health Agnes Buzyn, President Macron stressed the need for global collaboration to end the epidemics. France is a founding member of the Global Fund and will host the Global Fund's Sixth Replenishment Conference in Lyon on 10 October 2019.

The replenishment target comes at a crucial moment. The global community committed through the Sustainable Development Goals (SDGs) to end the epidemics of HIV, TB and malaria by 2030. But after years of remarkable progress in the fight against HIV, TB and malaria, new threats such as shortfalls in funding and increasing insecticide and drug resistance have slowed progress and enabled the diseases to gain ground.

"We now face a decisive moment. Do we step up the fight, or do we allow ourselves to slip back?" said Sands. "New threats mean there is no middle ground. We need to step up the fight to protect and build on the gains we have made, or we will see those achievements eroded, infections and deaths resurge, and the prospect of ending the epidemics disappear. It's time to deliver on that promise. If we step up the fight now, we will save millions more lives."

To save 16 million lives and work to achieve SDG 3, "health and well-being for all", the global community must innovate more, collaborate more, and execute more effectively. A successful replenishment of US$14 billion with enable the Global Fund to continue to play its vital role as catalyst and leader in the fight against HIV, TB and malaria.

"It is truly impressive to see how the Global Fund's impact has grown over the past 17 years," said Dr. Tedros. "It was an honor for me to chair its Board and I am excited now to have an opportunity to work with colleagues at the Global Fund on the new shared Global Action Plan for healthy lives and well-being for all."

Since its creation in 2002, the Global Fund partnership has had extraordinary impact. In the countries in which we invest, more than 27 million lives have been saved. The number of people dying from AIDS, TB and malaria has been slashed by one-third. In 2017 alone, results in countries where the Global Fund invests include 17.5 million people on antiretroviral therapy for HIV; 5 million people with TB treated; and 197 million mosquito nets distributed. The Global Fund delivers this impact together with a diverse range of partners including bilateral partners, multilateral and technical agencies, private sector companies, foundations, implementing countries, civil society groups, and people affected by the diseases.

The full Global Fund Sixth Replenishment Investment Case will be presented and discussed by global health leaders at the Preparatory Meeting of the Global Fund Sixth Replenishment, hosted by the government of India in New Delhi on 8 February 2019.

About The Global Fund 

The Global Fund is a 21st-century partnership designed to accelerate the end of AIDS, tuberculosis and malaria as epidemics. As a partnership between governments, civil society, the private sector and people affected by the diseases, the Global Fund mobilizes and invests nearly US$4 billion a year to support programs run by local experts in more than 100 countries. By challenging barriers and embracing innovative approaches, we are working together to better serve people affected by the diseases.

Click here to see the Investment Case.

Information on the work of the Global Fund is available at www.theglobalfund.org

Follow the Global Fund on Twitter: http://twitter.com/globalfund

Join the Global Fund on Facebook: http://www.facebook.com/theglobalfund

For more information, please contact: 

Melanie Brooks 
Communications
Mobile: +41-79-590-3047
E-mail: [email protected]

SOURCE The Global Fund


These press releases may also interest you

at 11:30
The "Global Antibody Therapeutic Market: Focus on Format, Disease Area, Route of Administration, End Users, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033" report has been added to  ResearchAndMarkets.com's offering. The global...

at 11:30
XtalPi Inc., a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced today the launch of its proprietary comprehensive solid...

at 11:25
Manifest Technologies, Inc., developer of an AI-powered computational neuro-imaging platform for CNS disease, today unveiled the company after completing its initial funding and partnership with a top five global pharmaceutical company. Today, over...

at 11:08
Sunwave Health, a leader in healthcare technology, proudly announces the launch of MARA, a patent-pending, innovative AI Agent designed to transform the landscape of behavioral health documentation. Since its launch on October 25, 2023, MARA has...

at 11:04
MelliCell Inc. has been awarded a U.S. National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $275,000 to conduct research and development (R&D) work on "Industrial Scale Technology for Drug Development in Mature Human...

at 11:00
Eagle Hill Consulting has earned another top workplace award, this time selected by The Washington Business Journal as a 2024 Best Places to Work in the extra-large sized company category. Eagle Hill also has earned multiple best workplace awards...



News published on and distributed by: